News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
359,530 Results
Type
Article (18489)
Company Profile (107)
Press Release (340921)
Multimedia
Podcasts (36)
Webinars (11)
Section
Business (100133)
Career Advice (615)
Deals (15941)
Drug Delivery (69)
Drug Development (47992)
Employer Resources (65)
FDA (9058)
Job Trends (8042)
News (171662)
Policy (14084)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
Academia (1603)
Accelerated approval (23)
Adcomms (11)
Allergies (97)
Alliances (28141)
ALS (141)
Alzheimer's disease (1113)
Antibody-drug conjugate (ADC) (300)
Approvals (9266)
Artificial intelligence (459)
Autoimmune disease (130)
Automation (35)
Bankruptcy (108)
Best Places to Work (7267)
BIOSECURE Act (19)
Biosimilars (165)
Biotechnology (79)
Bladder cancer (127)
Brain cancer (46)
Breast cancer (542)
Cancer (4191)
Cardiovascular disease (267)
Career advice (548)
Career pathing (16)
CAR-T (227)
CDC (20)
Cell therapy (668)
Cervical cancer (32)
Clinical research (42560)
Collaboration (1537)
Company closure (3)
Compensation (566)
Complete response letters (46)
COVID-19 (1383)
CRISPR (77)
C-suite (719)
Cystic fibrosis (112)
Data (5002)
Decentralized trials (1)
Denatured (11)
Depression (92)
Diabetes (329)
Diagnostics (3867)
Digital health (34)
Diversity (3)
Diversity, equity & inclusion (23)
Drug discovery (213)
Drug pricing (73)
Drug shortages (6)
Duchenne muscular dystrophy (157)
Earnings (40184)
Editorial (21)
Employer branding (8)
Employer resources (57)
Events (54721)
Executive appointments (792)
FDA (11514)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (8)
Frontotemporal dementia (19)
Funding (1290)
Gene editing (164)
Generative AI (40)
Gene therapy (473)
GLP-1 (491)
Government (2441)
Grass and pollen (3)
Guidances (304)
Healthcare (10692)
HIV (39)
Huntington's disease (34)
IgA nephropathy (61)
Immunology and inflammation (189)
Immuno-oncology (48)
Indications (84)
Infectious disease (1566)
Inflammatory bowel disease (165)
Inflation Reduction Act (8)
Influenza (88)
Intellectual property (188)
Interviews (91)
IPO (8022)
IRA (20)
Job creations (1149)
Job search strategy (475)
JPM (28)
Kidney cancer (16)
Labor market (18)
Layoffs (230)
Leadership (16)
Legal (1789)
Liver cancer (78)
Longevity (13)
Lung cancer (604)
Lymphoma (301)
Machine learning (37)
Management (20)
Manufacturing (642)
MASH (135)
Medical device (7391)
Medtech (7431)
Mergers & acquisitions (8682)
Metabolic disorders (788)
Multiple sclerosis (99)
NASH (14)
Neurodegenerative disease (229)
Neuropsychiatric disorders (55)
Neuroscience (2055)
Neurotech (1)
NextGen: Class of 2026 (3186)
Non-profit (2577)
Now hiring (17)
Obesity (305)
Opinion (162)
Ovarian cancer (150)
Pain (144)
Pancreatic cancer (203)
Parkinson's disease (239)
Partnered (24)
Patents (340)
Patient recruitment (391)
Peanut (40)
People (31700)
Pharmaceutical (22)
Pharmacy benefit managers (15)
Phase 1 (14601)
Phase 2 (18868)
Phase 3 (13732)
Pipeline (4236)
Policy (161)
Postmarket research (893)
Preclinical (5393)
Press Release (68)
Prostate cancer (205)
Psychedelics (18)
Radiopharmaceuticals (238)
Rare diseases (628)
Real estate (2632)
Recruiting (21)
Regulatory (13068)
Reports (24)
Research institute (1581)
Resumes & cover letters (58)
Rett syndrome (26)
RNA editing (16)
RSV (51)
Schizophrenia (108)
Series A (225)
Series B (173)
Service/supplier (5)
Sickle cell disease (73)
Special edition (8)
Spinal muscular atrophy (93)
Sponsored (31)
Startups (2057)
State (1)
Stomach cancer (18)
Supply chain (65)
Tariffs (31)
The Weekly (25)
Vaccines (603)
Venture capital (56)
Weight loss (143)
Women's health (53)
Worklife (4)
Date
Today (8)
Last 7 days (417)
Last 30 days (1720)
Last 365 days (22550)
2026 (2178)
2025 (22745)
2024 (24481)
2023 (26650)
2022 (34252)
2021 (35333)
2020 (31278)
2019 (24552)
2018 (18079)
2017 (17449)
2016 (15589)
2015 (17759)
2014 (12264)
2013 (9578)
2012 (9992)
2011 (10289)
2010 (8903)
Location
Africa (316)
Alabama (69)
Alaska (4)
Arizona (118)
Arkansas (11)
Asia (22252)
Australia (3302)
California (8157)
Canada (2146)
China (919)
Colorado (282)
Connecticut (380)
Delaware (235)
Europe (46432)
Florida (1260)
Georgia (240)
Hawaii (2)
Idaho (31)
Illinois (565)
India (51)
Indiana (420)
Iowa (20)
Japan (348)
Kansas (96)
Kentucky (30)
Louisiana (16)
Maine (43)
Maryland (1037)
Massachusetts (6178)
Michigan (228)
Minnesota (314)
Mississippi (6)
Missouri (99)
Montana (25)
Nebraska (12)
Nevada (86)
New Hampshire (44)
New Jersey (2210)
New Mexico (24)
New York (2171)
North Carolina (1112)
North Dakota (10)
Northern California (3968)
Ohio (211)
Oklahoma (19)
Oregon (24)
Pennsylvania (1642)
Puerto Rico (10)
Rhode Island (28)
South America (413)
South Carolina (55)
South Dakota (1)
Southern California (3206)
Tennessee (113)
Texas (1314)
United States (29044)
Utah (210)
Vermont (1)
Virginia (192)
Washington D.C. (39)
Washington State (642)
West Virginia (3)
Wisconsin (105)
Wyoming (2)
359,530 Results for "advanced biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
INTENT Biologics Receives FDA Agreement Granting a Full Waiver for its Pediatric Study Plan for PEP Biologic™ in Advanced Wound Care
January 22, 2026
·
3 min read
Press Releases
Precision Biologics Manufacturing Launches Advanced Biologics Facility
October 1, 2025
·
3 min read
Sponsored
Cracking the Code: Solving Microbial Manufacturing’s Biggest Challenges
Perfecting microbial manufacturing processes means taming its greatest asset: speed. This rapid process for creating biologics also means a race against time, where success hinges on conquering three key challenges: designing a robust microbial strain, optimizing fermentation for industrial scale, and ensuring consistent high-yield product yield.
December 1, 2025
·
6 min read
·
AGC Biologics
Press Releases
Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease
January 8, 2026
·
3 min read
Press Releases
BigHat Biosciences Partners With Lilly to Advance Machine-Learning-Enabled Biologics Discovery Through Lilly TuneLab
January 8, 2026
·
2 min read
Press Releases
HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
January 26, 2026
·
5 min read
Press Releases
Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline
January 13, 2026
·
3 min read
Press Releases
BenchSci and Mila Partner to Advance AI for Biological Inference and Accelerate Drug Discovery
November 13, 2025
·
3 min read
IN PARTNERSHIP WITH LOTTE BIOLOGICS
LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026
With inspections always on the table, LOTTE Biologics is pushing a proactive, quality first culture across its dual hubs in Syracuse and Songdo, backing its new single‑use ADC facility with rigorous training, self‑audits and real‑time regulatory surveillance.
January 19, 2026
·
2 min read
·
Jennifer Smith-Parker
Press Releases
Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Giuliana Rancic
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation in an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
February 1, 2026
·
3 min read
1 of 35,953
Next
